Jan 30, 2020   SOURCE: PR NewsWire

Cancer Stem Cells Market Expected to Generate Revenue of $ 1,722.7 Million, Growing at a CAGR of 10.3% by 2026

PUNE, India, Jan. 30, 2020 /PRNewswire/ -- According to Research Dive, Global Cancer Stem Cells Market will reach upto $1,722.7 million by the end of year 2026. Increasing number of patients of cancer, along with the recent technological advancements in cancer stem cells can drive the market by 2026.

https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg

Driving Factors of Cancer Stem Cells Market:

Increasing cases of cancer around the globe is noteworthy key factor which rise the cancer stem cells market growth. As per a publication by the World Health Organization (WHO), in low- and middle-income countries, around 70% of deaths occurs due to cancer.

Request sample report at https://www.researchdive.com/download-sample/32

The reasons for the increasing rate of cancer cases consist of smoking trends, genetic mutation, alcohol and hormones consumption, urban air pollution. In addition, inaccessible diagnosis & late-stage presentation are the factors responsible for increasing deaths of cancer patient. Contrary to this, stem cell research has capacity to produce medicines for cancer coupled with identifying drugs that can be used for cancer treatment. On the other hand, high cost cell therapies & stringent regulations such factors are reducing market growth. Living cells are used in these therapies to treat disease along with processes like, altering, storing and applying to technology. Therefore, the prices of stem cell therapies are very high which are around $5,000 to $8,000 per stem cell treatment coupled with it can upto $25,000.Recently, Tel Aviv University engineered advanced biosensor which can target leukemic stem cells along with these researchers are more looking on reducing the chances of relapse in blood cancer by targeting malignant leukemic stem cells. Such newest technological advancements estimated to surge the market growth. In Turkey, Stem cell research is the fast growing medical practice. Thus, Turkey is identified as 'rising star of Europe in stem cell' nowadays. Factors such as, friendliness, hospitality, modern laboratory equipment as well as 'high quality, low cost stem cell treatment', creating lucrative market for stem cells investors.

Enquire about market study https://www.researchdive.com/purchase-enquiry/32

Breast cancer market generated revenue of $133.7 million by 2018, and it is expected to grow at 10.4% CAGR by the end of 2026. Market is estimated to surge by 11.2% of CAGR, and can generate revenue of $275.8 million in 2026, increasing from $117.9 million by the end of 2018.

Stem cell based cancer therapy generated revenue of $440.3 million in 2018 and it is expected to rise upto 9.3% CAGR. Increased advancements in stem cell therapy is one of the significant factor for growth of this market.

North America cancer stem cell market is of $365.64 million in 2018 and it is estimated to grow at 10% CAGR.

Asia-Pacific cancer stem cell market is of $157.26 million in year of 2018.and it is estimated to rise up to 11.2% CAGR. Countries such as India, China, and Japan are the contributors to the growth of regional market

Top Key Players in Cancer Stem Cell Market:

Some of the major players in the global cancer stem cells market are:

    1. Advanced Cell Diagnostics, Inc.
    2. AdnaGen GmbH
    3. Celula, Inc.
    4. Epic Sciences
    5. Rarecells USA
    6. AVIVA Biosciences Corporation Inc.
    7. Fluxion Biosciences, Inc.
    8. Silicon Biosystems S.p.A

Such key players are taking initiatives to strengthen their presence such as merger & acquisitions, new product development etc .For instance, in April 2019, Celularity declared a long term lease agreement for the development of 145,000 square-foot advanced cell manufacturing and research facility in the U.S.

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Person:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+91(788)-802-9103 (India)
+1(917)-444-1262 (US)
Toll Free: 1-888-961-4454
E-mail: support@researchdive.com
Website: https://www.researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521

View original content:http://www.prnewswire.com/news-releases/cancer-stem-cells-market-expected-to-generate-revenue-of--1-722-7-million-growing-at-a-cagr-of-10-3-by-2026--300996071.html

SOURCE Research Dive